FBIO
Price:
$1.7164
Market Cap:
$47.38M
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the ...[Read more]
Industry
Biotechnology
IPO Date
2011-11-17
Stock Exchange
NASDAQ
Ticker
FBIO
According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 60.06M. This represents a change of 48.85% compared to the average of 40.35M of the last 4 quarters.
The mean historical Enterprise Value of Fortress Biotech, Inc. over the last ten years is 52.13M. The current 60.06M Enterprise Value has changed 11.42% with respect to the historical average. Over the past ten years (40 quarters), FBIO's Enterprise Value was at its highest in in the September 2020 quarter at 168.43M. The Enterprise Value was at its lowest in in the June 2022 quarter at -55255502.00.
Average
52.13M
Median
49.60M
Minimum
-26516462.50
Maximum
118.89M
Discovering the peaks and valleys of Fortress Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 314.71%
Maximum Annual Enterprise Value = 118.89M
Minimum Annual Increase = -1000.43%
Minimum Annual Enterprise Value = -26516462.50
Year | Enterprise Value | Change |
---|---|---|
2023 | 32.08M | 314.71% |
2022 | 7.74M | -129.17% |
2021 | -26516462.50 | -131.57% |
2020 | 83.98M | -29.36% |
2019 | 118.89M | 131.43% |
2018 | 51.37M | -56.76% |
2017 | 118.81M | 148.46% |
2016 | 47.82M | 39.78% |
2015 | 34.21M | -35.30% |
2014 | 52.88M | -1000.43% |
The current Enterprise Value of Fortress Biotech, Inc. (FBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.43M
5-year avg
43.23M
10-year avg
52.13M
Fortress Biotech, Inc.’s Enterprise Value is greater than Mustang Bio, Inc. (5.38M), greater than Achilles Therapeutics plc (-42104641.00), greater than Aptose Biosciences Inc. (24.71M), less than Fortress Biotech, Inc. (60.06M), less than Checkpoint Therapeutics, Inc. (163.76M), greater than Avenue Therapeutics, Inc. (1.08M), greater than Pieris Pharmaceuticals, Inc. (-1407736.00), greater than Aileron Therapeutics, Inc. (22.10M), less than Reviva Pharmaceuticals Holdings, Inc. (64.63M), greater than Eyenovia, Inc. (15.34M), greater than Cognition Therapeutics, Inc. (3.71M), greater than TransCode Therapeutics, Inc. (762.17K), less than Kodiak Sciences Inc. (370.50M), less than XOMA Corporation (291.00M), less than ZIVO Bioscience, Inc. (68.84M), greater than Lumos Pharma, Inc. (24.19M), less than Reviva Pharmaceuticals Holdings, Inc. (64.63M), greater than Athira Pharma, Inc. (-47430201.00), less than ACADIA Pharmaceuticals Inc. (2.75B), greater than Cabaletta Bio, Inc. (-40766966.00),
Company | Enterprise Value | Market cap |
---|---|---|
5.38M | $7.92M | |
-42104641.00 | $40.33M | |
24.71M | $13.99M | |
60.06M | $46.41M | |
163.76M | $168.46M | |
1.08M | $3.68M | |
-1407736.00 | $17.96M | |
22.10M | $39.76M | |
64.63M | $60.28M | |
15.34M | $9.52M | |
3.71M | $25.14M | |
762.17K | $2.49M | |
370.50M | $494.93M | |
291.00M | $301.03M | |
68.84M | $68.98M | |
24.19M | $37.54M | |
64.63M | $70.10M | |
-47430201.00 | $20.11M | |
2.75B | $2.86B | |
-40766966.00 | $114.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Fortress Biotech, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Fortress Biotech, Inc. (FBIO)?
What is the 3-year average Enterprise Value for Fortress Biotech, Inc. (FBIO)?
What is the 5-year average Enterprise Value for Fortress Biotech, Inc. (FBIO)?
How does the current Enterprise Value for Fortress Biotech, Inc. (FBIO) compare to its historical average?